Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Photogen Reports PDT Treatmentof Ocular Melanoma Promising

Facebook Twitter LinkedIn Email Comments
KNOXVILLE, Tenn., Dec. 10 -- Photogen Technologies reported that the findings of a researcher working under an agreement with the company show complete eradication of ocular melanoma tumors in 84% of lab animals following a single treatment with Photogen's multi-photon excitation (MPE) technology. Lucy Young, a researcher at Massachusetts Eye and Ear Infirmary, presented her results at the Retina Society Annual Meeting in Maui, Hawaii.
The study was based on the fact that melanin precursors become extremely phototoxic in melanoma tumor cells when activated with certain light sources. Treatment with MPE technology led to the death of tumorous cells, while leaving healthy tissue unharmed. No additional phototoxic agents were administered to achieve these results. Current treatments for ocular melanoma may involve surgery, radiation or even removal of the eye, said Young. I am pleased to share these highly promising results that I've found using Photogen's MPE technology with my colleagues at the Retina Society meeting.
Dec 1999
News & Features

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.